360 NEWS360 NEWS
Home / Healthcare

Sellas’ cancer vaccine extends survival in blood cancer trial, company says

The ⁠vaccine, called galinpepimut-S ⁠or GPS, was tested in patients with acute ​myeloid ‌leukaemia, a fast-growing cancer of the blood and bone marrow

Published
Original News Source The Hindu — Health
Source Website www.thehindu.com ↗
Content & Media Rights The Hindu — Health
Editorial Publisher 360 NEWS (Independent Media)
Sellas’ cancer vaccine extends survival in blood cancer trial, company says
Photo / Source: The Hindu — Health
The ⁠vaccine, called galinpepimut-S ⁠or GPS, was tested in patients with acute ​myeloid ‌leukaemia, a fast-growing cancer of the blood and bone marrow
360°

360° PERSPECTIVE

Verified viewpoints, counter-arguments & evidence

Perspective details for this viewpoint are currently being verified by our editorial desk.

Related Stories

Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].